Delivery Order SPE2DB22D1106-SPE2DB25FEPS6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,765.72 to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes with a completion date of September 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing for the pharmaceutical product delivery, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 8, 2025, for Ovidrel 250 mcg/0.5 ml syringes. The contract is valued at $2,189.70 and carries a firm fixed price structure with an ultimate completion date of August 11, 2025. This delivery order represents a non-set-aside award issued under competitive procedures, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Ovidrel 250 mcg/0.5 mL syringes, with a ceiling value of $4,201.80. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, awarded on August 11, 2025. This award carries no set-aside designation and represents a competitively awarded transaction. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $4,222.90 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ovidrel 250 mcg/0.5 mL syringes. This firm fixed-price contract, with an ultimate completion date of August 26, 2025, represents a single-line delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same municipality. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes, with a contract ceiling value of $3,323.09. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025, under a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order represents a...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for OVIDREL 250 MCG/0.5 ML syringes valued at $1,259.20 with a firm fixed price structure. The award, issued on July 26, 2025, is a non-set-aside competitive contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office operations serving federal medical...
- This is a $1,814.64 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the medication OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, with a completion date of July 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OVIDREL 250 MCG/0.5 ML SYRG 0.5ML pharmaceutical supplies. The contract has a potential value of $3,171.60 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order for the provision of Ovidrel 250 mcg/0.5 ml syringes. The award has a ceiling value of $3,171.60 and a performance period through April 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,529.97 firm fixed-price contract is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a medical product used in healthcare settings. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at $999,999,999 and running through...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEPS6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,305.13 to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes. The award, issued on May 22, 2025, with an ultimate completion date of May 23, 2025, represents a firm fixed price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. Ovidrel is a human chorionic gonadotropin (hCG) medication commonly used in fertility treatments and reproductive health applications. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor serving federal medical procurement needs, supplies an extensive portfolio of pharmaceutical products and medical supplies to military and veteran healthcare systems through competitively awarded contracts. The company's federal contract awards demonstrate a broad capability to fulfill diverse medical supply requirements, ranging from specialty medications and vaccines to specialized medical devices and diagnostics. This particular delivery order reflects the ongoing operational need for pharmaceutical products within the Defense Health Agency's medical supply chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 5/22/25 |